Advertisement
Screener

PharMerica CORP Excess Tax Benefit from Share-based Compensation, Financing Activities

PharMerica CORP Excess Tax Benefit from Share-based Compensation, Financing Activities

PharMerica CORP reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.

Discontinued › Notes › Compensation Related Costs

us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2017-02-24

  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $2.40M, a 29.41% decline from fiscal 2014.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $3.40M, a 750.00% increase from fiscal 2013.
  • PharMerica CORP excess tax benefit from share-based compensation, financing activities for fiscal 2013 was $400.00K.
Period endExcess Tax Benefit from Share-based Compensation, Financing Activities 3 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 6 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 9 monthExcess Tax Benefit from Share-based Compensation, Financing Activities 12 month
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$0.00
derived: sum of 2 quarters · filed 2017-02-24
$0.00
derived: sum of 3 quarters · filed 2017-02-24
$0.00
10-K · filed 2017-02-24
2016-09-30$0.00
10-Q · filed 2016-11-09
$0.00
derived: sum of 2 quarters · filed 2016-11-09
$0.00
10-Q · filed 2016-11-09
$100.00K
derived: sum of 4 quarters · filed 2017-02-24
2016-06-30$0.00
10-Q · filed 2016-08-09
$0.00
10-Q · filed 2016-08-09
$100.00K
derived: sum of 3 quarters · filed 2017-02-24
$300.00K
derived: sum of 4 quarters · filed 2017-02-24
2016-03-31$0.00
10-Q · filed 2016-05-06
$100.00K
derived: sum of 2 quarters · filed 2017-02-24
$300.00K
derived: sum of 3 quarters · filed 2017-02-24
$500.00K
derived: sum of 4 quarters · filed 2017-02-24
2015-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$300.00K
derived: sum of 2 quarters · filed 2017-02-24
$500.00K
derived: sum of 3 quarters · filed 2017-02-24
$2.40M
10-K · filed 2017-02-24
2015-09-30$200.00K
10-Q · filed 2016-11-09
$400.00K
derived: sum of 2 quarters · filed 2016-11-09
$2.30M
10-Q · filed 2016-11-09
$2.30M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$200.00K
10-Q · filed 2016-08-09
$2.10M
10-Q · filed 2016-08-09
$2.10M
derived: sum of 3 quarters · filed 2017-02-24
$2.30M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$1.90M
10-Q · filed 2016-05-06
$1.90M
derived: sum of 2 quarters · filed 2017-02-24
$2.10M
derived: sum of 3 quarters · filed 2017-02-24
$2.60M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$200.00K
derived: sum of 2 quarters · filed 2017-02-24
$700.00K
derived: sum of 3 quarters · filed 2017-02-24
$3.40M
10-K · filed 2017-02-24
2014-09-30$200.00K
10-Q · filed 2015-11-06
$700.00K
derived: sum of 2 quarters · filed 2015-11-06
$3.40M
10-Q · filed 2015-11-06
$3.40M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$500.00K
10-Q · filed 2015-08-07
$3.20M
10-Q · filed 2015-08-07
$3.20M
derived: sum of 3 quarters · filed 2016-02-26
$3.20M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$2.70M
10-Q · filed 2015-05-07
$2.70M
derived: sum of 2 quarters · filed 2016-02-26
$2.70M
derived: sum of 3 quarters · filed 2016-02-26
$2.90M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$0.00
derived: sum of 2 quarters · filed 2016-02-26
$200.00K
derived: sum of 3 quarters · filed 2016-02-26
$400.00K
10-K · filed 2016-02-26
2013-09-30$0.00
10-Q · filed 2014-11-06
$200.00K
derived: sum of 2 quarters · filed 2014-11-06
$400.00K
10-Q · filed 2014-11-06
$400.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$200.00K
10-Q · filed 2014-08-05
$400.00K
10-Q · filed 2014-08-05
$400.00K
derived: sum of 3 quarters · filed 2015-03-02
$400.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$200.00K
10-Q · filed 2014-05-01
$200.00K
derived: sum of 2 quarters · filed 2015-03-02
$200.00K
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$0.00
derived: sum of 2 quarters · filed 2015-03-02
$0.00
10-K · filed 2015-03-02
2012-09-30$0.00
10-Q · filed 2013-11-05
$0.00
10-Q · filed 2013-11-05